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Abstract
OBJECTIVE: To explore the effect of Tongluojiunao
injection (TLJN) prepared with Sanqi (Radix No-
toginseng) and Zhizi (Fructus Gardeniae) on the in-
teraction between brain microvascular endothelial
cells (BMECs) and astrocytes in an in vitro ischemic
model.
METHODS: First, an in vitro model of cerebral isch-
emia in BMECs or astrocytes was established by ox-
ygen-glucose deprivation (OGD). TLJN was used as
a medicine of intervention. The OGD-injured
BMECs were cultured in various astrocyte-condi-
tioned media. Cell activity, alkaline phosphatase
(AKP) and γ-glutamyl transpeptidase (γ-GT) activity,
interleukin-1 beta (IL-1β), and tumor necrosis factor
alpha (TNF-α) content in BMECs were determined.
Additionally, OGD-injured astrocytes were cultured
in various BMEC-conditioned media. Cell activity, as
well as expression of brain-derived neurotrophic
factor (BDNF) and glial cell-derived neurotrophic
factor (GDNF) in astrocytes, were detected.
RESULTS: The results of paracrine signaling of nor-
mal BMECs or astrocytes showed a protective effect
on each other: conditioned media from normal as-
trocytes improved cell viability, AKP, and γ-GT activi-
ty, and reduced IL-1β and TNF-α content of injured
BMECs; conditioned media from normal BMECs im-
proved cell viability and expression of BDNF and
GDNF in injured astrocytes. However, once the
BMECs or astrocytes were injured by OGD, the pro-
tective effect decreased or disappeared. The
above-mentioned protective induction was effec-
tively recovered by TLJN intervention.
CONCLUSION: The therapeutic benefit of TLJN was
achieved by recovering two-way induction be-
tween BMECs and astrocytes, enhancing activity of
injured BMECs and astrocytes, stabilizing enzymat-
ic barriers, promoting expression of neurotrophic
factors, and inhibiting inflammatory cytokines.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Ischemic stroke is a common, lethal disease with char-
acteristics of a high incidence, high disability rate, and
high recurrence rate.1 Despite better insight into the
pathogenesis of stroke, current therapies for this devas-
tating disease are far from optimal. Early investigations
primarily focused on prevention of neuronal death.
However, all promising experimental neuroprotective
treatments that specifically target neurons have failed
in clinical trials.2 With the proposal of the "neurovascu-
lar unit" hypothesis in recent years, a paradigm shift
took place that shifts the emphasis of stroke research
from a purely neurocentric focus to a more integrated
view, wherein dynamic interactions occur between neu-
rons, glia, and cerebral endothelium.3 Researchers grad-
ually realized that the microenvironment of neurons,
composed of astrocytes, endothelial cells, pericytes, and
extracellular matrix, may have an important impact on
neuronal survival and their functions.4,5 More attention
should be paid to the influence of damaged astrocytes
and brain microvascular endothelial cells (BMECs) on
neuronal functions in ischemic conditions. In terms of
brain ultrastructure, astrocytic end-feet firmly sur-
round the cerebral microvascular endothelial cells, re-
sulting in a close relationship between brain parenchy-
mal cells.6,7 In other words, under physiological and
pathological conditions, BMEC and astrocyte func-
tions are closely associated with one another, and they
may influence each other through intercellular commu-
nication molecules that are essential for the mainte-
nance of normal brain function and pathological evolu-
tion induced by ischemic damage.2 Therefore, thera-
pies with pleiotropic activity, especially saving the func-
tional interaction across multiple cell types, will be-
come increasingly useful in ischemic stroke treatments.
The Tongluojiunao injection (TLJN), literally mean-
ing "dredging-collaterals and saving-brain injection", is
made from a recipe consisting of Chinese herbs Sanqi
(Radix Notoginseng) and Zhizi (Fructus Gardeniae)
based on Traditional Chinese Medicine (TCM). TLJN
has mainly been used for the treatment of ischemic ce-
rebral stroke. Previous studies have shown that TLJN
protects injured neurons by regulating paracrine signal-
ing of BMECs, as well as inhibiting proliferative activi-
ty of microglial cells by downregulating macrophage in-
flammatory protein-1 beta (MIP-1β) in BMECs.8,9
These results suggested that the therapeutic benefit of
TLJN was attributed to signaling between BMECs, mi-
croglial cells, and neurons. The present study focused
on the paracrine signal exchange of BMECs and astro-
cytes, and explored the paracrine interaction between
BMECs and astrocytes in an in vitro ischemic model.
MATERIALS ANDMETHODS
Isolation and culture of BMECs
Male Sprague-Dawley (SD) rats, weighing 60-70 g,
were purchased from Beijing Vital River Laboratory
Animals (Beijing, China, certificate of quality No.
SCXK2006-0009). All studies were performed with
the approval of the experimental animal committee of
our university. In the experiments, measures were tak-
en to minimize the number of animals used and their
suffering according to the European Community
Guidelines (EEC Directive of 1986).
Isolation and culture of primary BMECs were per-
formed as previously described.10 Briefly, isolated cere-
bral gray matter was passed through 200-μm and
74-μm mesh following homogenization. Tissue remain-
ing on the 74-μm mesh screen was digested by typeⅡ
collagenase (0.2%) at 37℃ for 20 min, and then the
microvessel fragments were collected after centrifuga-
tion of the matter digested at room temperature for
5 min at 200 ×g. The fragments containing microves-
sels were seeded onto gelatin-coated dishes. Cells from
the third passage were used for the following experi-
ments.
Isolation and culture of rat astrocytes
Isolation and culture of rat astrocytes were taken from
neonatal (postnatal day 1) SD rats according to Redzic
et al 11 Briefly, the cortex was cut into pieces, and tissue
fragments were treated with 0.125% trypsin at 37℃
for 25 min. Then, digestion was stopped by DMEM
supplemented with 10% FBS, followed by pipetting
and passage through a 74-μm mesh. The cells were re-
suspended in complete culture medium (DMEM-H,
3.7 mg/mL NaHCO3, 4.766 mg/mL Hepes, 10%
FBS, 100 U/mL penicillin and 100 μg/mL streptomy-
cin, pH 7.2-7.4) at a concentration of 1.0×106/mL and
seeded on poly-D-lysine-coated dishes. At 90% conflu-
ence 8 days later, the cells were put into a thermostat
shaker at 37℃ with an oscillation speed of 240 rpm for
18 h to separate microglia and oligodendrocytes from
astrocytes.
In vitro models of ischemia in rat MVECs and
astrocytes
The mimic ischemic model of BMECs was prepared
by oxygen-glucose deprivation (OGD) as previously de-
scribed.8 The cells were exposed to a sugar-free Krebs
solution (6.9 g NaCl, 0.35 g KCl, 0.16 g KH2PO4, 2.1 g
NaHCO3, 0.28 g CaCl2, 0.2 g MgCl2, dissolved into 1 L
water, pH 7.3) in a 95% N2 and 5% CO2 environment
for 6 h.
The in vitro ischemic model of astrocytes was also made
by OGD according to the method of Wang et al 12 The
astrocytes were exposed to a sugar-free Krebs solution
in a 95% N2 and 5% CO2 environment for 8 h (injury
time was determined by MTT assay in a preliminary
study).
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Collection of conditioned media from BMECs or
astrocytes
TLJN was provided by Tianjin Chase Sun Pharmaceu-
tical Company (Tianjin, China, Lot 1108301) and was
extracted from the Chinese herbs Sanqi (Radix Notogin-
seng) and Zhizi (Fructus Gardeniae). Processing was per-
formed according to the protocol of the National Med-
ical Dictionary of China, as described by Wang et al 9
The main component of TLJN was determined as geni-
poside (4.95 mg/mL, C17H24O10, MW 388), ginsenno-
side Rg1 (1.02 mg/mL, C42H72O14, MW 800), and
geniposidic acid (1.73 mg/mL, C16H22O10, MW 374)
by HPLC analysis.9
BMECs were divided into three groups: normal
BMECs, OGD-injured BMECs, and OGD-injured
BMECs treated with TLJN at a concentration of 2 μL/
mL.8 The BMEC-culture medium was replaced with
serum-free medium, and after 6 h the supernatant was
harvested as conditioned media. The supernatants were
labeled as follows: conditioned medium from normal
BMECs (EC-N-CM), OGD-injured BMECs
(EC-I-CM), and from OGD-injured BMECs treated
with TLJN (EC-IT-CM).
According to the above-mentioned method, condi-
tioned medium was collected from normal astrocytes
(As-N-CM), from OGD-injured astrocytes (As-I-CM),
and from OGD-injured astrocytes treated with TLJN
(As-IT-CM).
Groups and treatment of BMECs or astrocytes
The normal control group was composed of astrocytes
cultured in astrocyte culture medium. The remaining
astrocytes were injured by OGD and then divided into
four groups: (a) serum-free medium as model control;
(b) in EC-N-CM; (c) in EC-I-CM; and (d) in
EC-IT-CM. The astrocytes were cultured for 12 h for
the following experiments.
BMECs were also divided into five groups according
to the above methods. In addition to normal and mod-
el control groups, three additional groups of BMECs
were respectively cultured in As-N-CM, As-I-CM, and
As-IT-CM.
MTT assay
Cell activity in BMECs or astrocytes was determined
using the MTT assay. A total of 10 μL MTT (1 mg/
mL) was added to each culture well. After incubation
for 4 h at 37℃ , the supernatant was removed and 100
μL DMSO was added to each well. Absorbance (OD)
of the produced formazan was measured at 570 nm
with 620 nm as a reference wavelength using a micro-
plate reader.
AKP and γ-GT activity assay
First, BMECs cultured in various astrocyte-condi-
tioned media were lysed on ice. Total protein was col-
lected after centrifugation at 10000 r/min for 20 min,
and quantified by BCA™ Protein Quantification Kit.
AKP or γ-GT activity in BMECs was determined ac-
cording to an AKP or γ-GT activity assay kit. Briefly,
assay reaction mixture was added to each well of AKP
standard, blank control, and test samples. After incu-
bating the reaction at the desired temperature, the OD
value was detected. AKP activity was calculated as the
following formula:
AKP (U/g prot) =(sample OD value－ blank OD value)/(stan-
dard OD value－blank OD value)×0.02/protein quantityγ-GT activity was calculated as the following formula:γ-GT (U/g prot) =(sample OD value － blank OD value) ×
232.56/ protein quantity
Enzyme-linked immunosorbent assays (ELISA)
The IL-1β and TNF-α contents in BMECs were mea-
sured using a commercially available ELISA kit (Neo
Bioscience, China) according to the manufacturer's in-
structions. The readings were collected from multiple
(n=4-5) independent samples for each experimental
condition.
Western blot
BDNF and GDNF expression in astrocytes cultured in
various BMEC-conditioned media was detected by
western blot analysis according to standard protocols.
In brief, a total protein sample was collected by lysing
cells and quantified according to the bicinchoninic ac-
id method. All protein samples were separated by
SDS-PAGE on 12% polyacrylamide gels, and subse-
quently transferred to a nitrocellulose membrane. The
membranes were blocked for 1 h in 100 mM PBS con-
taining 5% nonfat milk powder and 0.3% Tween-20,
then incubated with BDNF (1∶5000) or GDNF (1∶
100) monoclonal antibodies overnight at 4℃ . After
three washes, the membranes were incubated for 1 h at
37℃ with appropriate secondary antibody (1∶1000).
Bands were visualized using Enhanced Chemi-Lumi-
nescence (ECL) and analyzed on a motored molecular
imaging system (Tanon-4500).
Statistical analysis
All measures were summarized as mean±standard devia-
tion (SD). The data were analyzed with the SPSS 17.0
statistical package (SPSS Co, Chicago, IL, USA).
One-way analysis of variance (ANOVA) was used to
determine differences among the groups. A P value<
0.05 was deemed statistically significant.
RESULTS
Activity of BMECs cultured in various
astrocyte-conditioned media
The MTT assay was used to detect activity of BMECs
cultured in various astrocyte-culture-conditioned me-
dia. As shown in Figure 1A, the OD value in the mod-
el group was significantly decreased compared with the
normal control (P<0.001), indicating that BMEC via-
bility decreased by OGD. Compared with the model
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control, the OD value in As-N-CM groups increased
(P<0.01), which indicated that As-N-CM improves vi-
ability of injured BMECs. The OD value in As-I-CM
had no significant change compared with the model
control, indicating As-I-CM had no effect on the via-
bility of injured BMECs. Compared with the As-I-CM
group, the OD value in the As-IT-CM group signifi-
cantly increased (P<0.01), showing that As-IT-CM
had a protective effect on injured BMECs.
AKP and γ-GT activity in BMECs
AKP activity in BMECs cultured in various astro-
cyte-culture-conditioned media is shown in Figure 1B.
Compared with the normal control, enzyme activity of
AKP in the model group significantly decreased (P<
0.001), showing that OGD injury leads to decreased
AKP activity in BMECs. Compared with the model
group and the normal control group, AKP activity in
the As-N-CM group significantly increased (P<0.001),
suggesting that normal astrocyte-conditioned medium
significantly induced AKP activity of BMECs. In the
As-I-CM group, AKP activity compared with the mod-
el group had no changes, suggesting that the inducing
effect of injured astrocytes on AKP activity in BMECs
had disappeared. Compared with the As-I-CM group,
AKP activity in the As-IT-CM group increased (P<
0.01), suggesting that TLJN injection improved the in-
ducing effect of injured astrocytes on AKP activity in
BMECs.γ-GT activity in BMECs is shown in Figure 1C. After
OGD for 6 h (model group), γ-GT activity in BMECs
significantly decreased compared with the normal con-
trol (P<0.001). There was a significant difference be-
tween model and As-N-CM groups (P<0.001), and
normal AS-conditioned media significantly increasedγ-GT activity of injured BMECs. As-I-CM also
showed an inductive effect, but this effect was weaker
than As-N-CM. γ-GT activity in the As-IT-CM group
significantly increased (P<0.001), suggesting thatγ-GT activity induced by astrocyte paracrine signaling
was enhanced by TLJN intervention.
IL-1β and TNF-α content in BMECs
The IL-1β and TNF-α contents in BMECs were mea-
sured by ELISA. As shown in Figure 2A, compared
with the normal group, IL-1β levels of BMECs in the
model group were significantly greater (P<0.001), indi-
cating that OGD induced inflammatory factor IL-1β
expression in BMECs. Compared with the model
group, IL-1β levels in the As-N-CM and As-I-CM
groups significantly decreased (P<0.001, P<0.05, re-
spectively), suggesting that both astrocyte-conditioned
media inhibited expression of IL-1β in BMECs, al-
though the effect of As-I-CM was significantly weaker
than As-N-CM. Compared with the As-I-CM group,
IL-1β levels in the As-IT-CM group significantly de-
creased (P<0.05).
TNF-α content in BMECs is shown in Figure 2B.
Compared with the normal group, TNF-α content in
the model group was significantly greater (P<0.001),
indicating that OGD also induced TNF-α expression
in BMECs. Compared with the model group, TNF-α
content in the As-N-CM groups decreased (P<0.01),
which indicates that normal astrocyte-conditioned me-
dia inhibited expression of TNF-α in BMECs. Howev-
er, As-I-CM had no effect on TNF-α expression in
BMECs (P>0.05). Compared with the As-I-CM
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Figure 1 Changes in cell activity, AKP activity, and γ-GT activ-
ity in BMECs cultured in various astrocyte-conditioned me-
dia
A: change of BMEC mitochondrial activity as determined by
the MTT assay; B: change of AKP activity in BMECs; C:
change of γ-GT activity in BMECs. Normal control: BMECs
were cultured in 100% BMEC-culture medium; model:
OGD-injured BMECs were cultured in serum-free medium;
As-N-CM: OGD-injured BMECs were cultured in conditioned
medium from normal astrocytes; As-I-CM: OGD-injured
BMECs were cultured in conditioned medium from injured
astrocytes; As-IT-CM: OGD-injured BMECs were cultured in
conditioned medium from injured astrocytes treated with
TLJN. AKP: alkaline phosphatase; γ-GT: γ-glutamyl transpep-
tidase; BMECs: brain microvascular endothelial cells; OGD:
oxygen-glucose deprivation; MTT: methyl thiazolyl tetrazoli-
um; TLJN: Tongluojiunao injection. aP<0.01 and dP<0.001,
compared with normal control group; fP<0.05, bP<0.01 and
eP<0.001, compared with model group; cP<0.01 and gP<
0.001, compared with As-I-CM group.
Groups
f
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group, TNF-α content in the As-IT-CM group had a
decreasing tendency, but there was no significant differ-
ence.
Activity of astrocytes cultured in various
BMEC-conditioned media
The activity of astrocytes was determined by MTT as-
say. As shown in Figure 3, the OD value in the model
group was significantly less compared with the normal
control (P<0.001), indicating the successful imitation
of ischemic injury model in astrocytes. For these
OGD-injured astrocytes, we further detected the effect
of three different BMEC cultural media on them. As
shown, the OD values in EC-N-CM group presented
an obvious increase compared with the model group
(P<0.001), suggesting that normal BMEC-conditioned
medium significantly improved the activity of injured
astrocytes, showing a protective effect on astrocytes.
OD values in the EC-I-CM group also increased com-
pared with the model group (P<0.01), but less signifi-
cantly than EC-N-CM, indicating that the protective
effect of BMEC secretion on astrocytes became weak
when BMECs were injured. Compared with the
EC-I-CM group, the OD value in the EC-IT-CM
group significantly increased (P<0.001), suggesting
that the protective effect of BMEC secretion on astro-
cytes was improved by TLJN intervention.
BDNF and GDNF expression in astrocytes
BDNF and GDNF expression in astrocytes cultured in
various BMEC-conditioned media was analyzed by
western blot analysis. As shown in Figure 4, BDNF ex-
pression in the model group significantly decreased
compared with the normal control (P<0.001), indicat-
ing a reduction in BDNF expression in injured astro-
cytes under the OGD condition for 8 h. Compared
with the model group, BDNF expression in the
EC-N-CM group significantly increased (P<0.01), in-
dicating that the normal BMEC-conditioned medium
enhanced BDNF expression in OGD-injured astro-
cytes. Compared with the model group, BDNF expres-
sion in the EC-I-CM group was not significantly differ-
ent. Compared with the EC-I-CM group, BDNF ex-
pression in EC-IT-CM group increased (P<0.05), sug-
gesting that TLJN injection improved the inducing ef-
fect of injured BMECs on BDNF expression in astro-
cytes.
GDNF expression in astrocytes is shown in Figure 5.
Compared with the normal control, GDNF expression
in the model group significantly decreased (P<0.001).
Compared with the model group, GDNF expression
in EC-N-CM significantly increased (P<0.05), suggest-
ing that normal BMEC-conditioned medium up-regu-
lated GDNF expression in astrocytes. However,
LiWH et al. / Experimental Study
140
120
100
80
60
40
20
0
d
b
e
Normal
control
Model As-N-CMAs-I-CMAs-IT-CM
TN
F-α
con
ten
t(p
g/g
pro
t)
700
600
500
400
300
200
100
0
a
acb
Normal
control
Model As-N-CMAs-I-CMAs-IT-CM
IL-
1β
con
ten
t(p
g/g
pro
t)
Figure 2 Changes of IL-1β and TNF-α content in BMECs cul-
tured in various astrocyte-conditioned media, as deter-
mined by ELISA assay
A: change of IL-1β content in BMECs; B: change of TNF-α
content in BMECs. Normal control: BMECs were cultured in
100% BMEC-culture medium; model: OGD-injured BMECs
were cultured in serum-free medium; As-N-CM: OGD-in-
jured BMECs were cultured in conditioned medium from
normal astrocytes; As-I-CM: OGD-injured BMECs were cul-
tured in conditioned medium from injured astrocytes;
As-IT-CM: OGD-injured BMECs were cultured in conditioned
medium from injured astrocytes treated with TLJN. BMECs:
brain microvascular endothelial cells; OGD: oxygen-glucose
deprivation; IL-1β: interleukin-1 beta; TNF-α: tumor necrosis
factor alpha; TLJN: Tongluojiunao injection; ELISA: en-
zyme-linked immunosorbent assay. aP<0.001, bP<0.05, and
eP<0.01, compared with model group, cP<0.001, compared
with As-I-CM group; dP<0.001, compared with normal con-
trol group.
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Figure 3 Change of activity in astrocytes cultured in various
BMEC-conditioned media by MTT assay
Normal control: astrocytes were cultured in 100% astrocyte
culture medium; model: OGD-injured astrocytes were cul-
tured in serum-free medium; EC-N-CM: OGD-injured astro-
cytes were cultured in conditioned medium from normal
BMECs; EC-I-CM: OGD-injured astrocytes were cultured in
conditioned medium from injured BMECs; EC-IT-CM:
OGD-injured astrocytes were cultured in conditioned medi-
um from injured BMECs treated with TLJN. BMECs: brain mi-
crovascular endothelial cells; OGD: oxygen-glucose depriva-
tion; MTT: methyl thiazolyl tetrazolium; TLJN: Tongluojiunao
injection. aP<0.001, compared with normal control group;
cP<0.01 and bP<0.001, compared with model group, dP<
0.001, compared with EC-I-CM group.
Groups
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EC-I-CM had no effect on GDNF expression in astro-
cytes (P>0.05). Compared with the EC-I-CM group,
GDNF expression of astrocytes in the EC-IT-CM
group increased, but the change was not significant.
DISCUSSION
Previous studies have shown that TLJN protects brain
tissue against ischemia in middle cerebral artery occlu-
sion rat models by reducing infarct volume and penum-
bra size.13,14 However, the pharmacological mechanisms
underlying its efficacy remain poorly understood. In vi-
tro experiments have shown that TLJN directly pro-
tects OGD-injured BMECs and neurons.15,16 In the
present study, indirect protection of TLJN on
OGD-injured BMECs and astrocytes was observed by
way of collecting conditioned media from TLJN-treat-
ed cells. As shown in the MTT results, conditioned me-
dia from normal BMECs improved the viability of in-
jured astrocytes and conditioned media from normal
astrocytes also improved the viability of injured
BMECs suggesting that the survival of cells could be
supported by the survival of others. However, once
BMECs or astrocytes were injured by OGD, mutual
induction decreased or disappeared. The conditional
media from injured BMECs (astrocytes) treated with
TLJN, unlike that of injured, untreated BMECs (astro-
cytes), also presented a protective effect, indicating that
TLJN effectively recovered the interaction between
BMECs and astrocytes by regulating paracrine signal-
ing of the two cell types.
The blood-brain barrier is made up of brain capillaries.
The brain endothelium possesses different properties
from peripheral capillaries, e.g. tight junctions, less en-
docytosis, and a specific transport system. In particu-
lar, the brain endothelium contains a number of en-
zyme systems, such as AKP, γ-GT, and monoamine ox-
idase.17 In vitro experiments have demonstrated thatγ-GT and AKP activity in BMECs is much greater
than in endothelial cells from other organs,18 which
was regarded as one of the characteristics of the
blood-brain barrier. The physiological function of
these enzymes is not exactly clear. Evidence has shown
that high activity of γ-GT and AKP may support pro-
tective and detoxifying roles of the BBB by impacting
active transport and facilitated diffusion.19 In our
study, γ-GT and AKP activity in BMECs significantly
decreased when BMECs were injured by OGD. The
conditional media from normal astrocytes improve
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Figure 4 BDNF expression in astrocytes cultured in various
BMEC-conditioned media as determined by western blot
analysis
A: representative blots of BDNF and β-actin (loading con-
trol) from different groups. 1: normal control; 2: model; 3:
EC-N-CM; 4: EC-I-CM; 5: EC-IT-CM. Western blots were
probed with anti-BDNF monoclonal antibody. The experi-
ment was repeated three times with similar results. B: densi-
ties of the bands quantified on a motored molecular imag-
ing system (Tanon-4500). Normal control: BMECs were cul-
tured in 100% BMEC-culture medium; model: OGD-injured
BMECs were cultured in serum-free medium; As-N-CM:
OGD-injured BMECs were cultured in conditioned medium
from normal astrocytes; As-I-CM: OGD-injured BMECs were
cultured in conditioned medium from injured astrocytes;
As-IT-CM: OGD-injured BMECs were cultured in conditioned
medium from injured astrocytes treated with TLJN. BMECs:
brain microvascular endothelial cells; OGD: oxygen-glucose
deprivation; BDNF: brain-derived neurotrophic factor; TLJN:
Tongluojiunao injection. aP<0.001, compared with normal
control group; bP<0.01and cP<0.001, compared with model
group; dP<0.05, compared with EC-I-CM group.
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Figure 5 GDNF expression in astrocytes cultured in various
BMEC-conditioned media as assessed by western blot
A: representative blots of GDNF and β-actin from different
groups. 1: normal control; 2: model; 3: EC-N-CM; 4: EC-I-CM;
5: EC-IT-CM. B: band densities of western blot quantified on
a motored molecular imaging system (Tanon-4500). Normal
control: BMECs were cultured in 100% BMEC-culture medi-
um; model: OGD-injured BMECs were cultured in serum-free
medium; As-N-CM: OGD-injured BMECs were cultured in
conditioned medium from normal astrocytes; As-I-CM:
OGD-injured BMECs were cultured in conditioned medium
from injured astrocytes; As-IT-CM: OGD-injured BMECs were
cultured in conditioned medium from injured astrocytes
treated with TLJN. BMECs: brain microvascular endothelial
cells; GDNF: glial cell-derived neurotrophic factor; OGD: oxy-
gen-glucose deprivation; TLJN: Tongluojiunao injection. aP<
0.001, compared with normal control group; bP<0.05 com-
pared with model group.
A
B
Groups
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γ-GT and AKP activity in injured BMECs, suggesting
induction of astrocytes on γ-GT and AKP activity in
BMECs, which was consistent with previous literature
reports.15 However, induction of injured astrocytes sig-
nificantly decreased, or in some cases even disappeared.
The decreased induction in injured astrocytes was re-
versed by TLJN administration, indicating that TLJN
indirectly increased γ-GT and AKP activity in BMECs
by regulating paracrine signaling of astrocytes.
Evidence suggests that immune-inflammatory respons-
es are the key elements in the physiopathological pro-
cesses associated with ischemic injury,20 and further trig-
ger excessive production of proinflammatory cytokines
in the brain and in peripheral blood, including
TNF-α, IL-1β, and IL-6. These inflammatory cyto-
kines mediate diverse responses to ischemic injury,
which involves exacerbated brain damage in the early
stages and accelerated repair in later stages. Previous
studies have demonstrated that TNF-α and IL-1β play
a crucial role in aggravating brain damage. In addition
to activating inflammatory cells, facilitating adhesion
and chemotaxis, and disrupting the blood-brain barri-
er, TNF-α and IL-1β have a direct neurotoxic effect
by inducing neuronal apoptosis.21-23 The major cellular
elements capable of TNF-α and IL-1β production in
the brain have been identified in multiple cell types,
such as astrocytes, microglia, endothelial cells, and mac-
rophages. In our study, we observed the impact of as-
trocytes on TNF-α and IL-1β expression in BMECs.
Our results showed TNF-α and IL-1β content were
significantly up-regulated in OGD-injured BMECs, in-
dicating that mimicry of ischemic injury induced re-
lease of the proinflammatory cytokines TNF-α and
IL-1β in BMECs. TNF-α and IL-1β overexpression in
injured BMECs were significantly inhibited by condi-
tioned medium from normal astrocytes. Conditioned
medium from injured astrocytes presented significantly
weaker inhibition on IL-1β overexpression and had no
effect on TNF-α overexpression in BMECs, suggesting
paracrine signaling of normal astrocytes regulates in-
flammatory responses in BMECs to ischemic injury,
but injured astrocytes lose these regulatory abilities.
TLJN effectively recovered the regulatory abilities of in-
jured astrocytes.
Neurotrophic factors are a group of proteins or pep-
tides with special nutritional effects on nerve tissues.24
Endogenous neurotrophic factors, such as BDNF and
GDNF, are regarded as protective agents against isch-
emia reperfusion injury. It was reported that BDNF
and GDNF alleviated neuronal damage in the early
stage of cerebral ischemia injury,25 as well as facilitating
neurogenesis and neurite growth in the later stage,
which could benefit regeneration and repair of brain in-
jury.26,27 It is generally recognized that BDNF and
GDNF are mainly derived from astrocytes. However,
recent research showed that BDNF and GDNF expres-
sion is not only regulated by astrocytes, but also by dif-
ferent types of cells in the neurovascular unit.28 There-
fore, we explored paracrine signaling of BMECs on ex-
pression of BDNF and GDNF in astrocytes. Our re-
sults showed that BDNF and GDNF expression were
significantly down-regulated when astrocytes were in-
jured by OGD. The conditional medium from normal
BMECs improved BDNF and GDNF expression in in-
jured astrocytes. However, paracrine signaling of in-
jured BMECs showed less beneficial effects on expres-
sion of both neurotrophic factors, which was ameliorat-
ed by TLJN intervention.
TLJN effectively recovered the two-way induction be-
tween BMECs and astrocytes by regulating paracrine
signaling. Therefore, we speculate that the therapeutic
benefit of TLJN was achieved by regulating interaction
of BMECs and astrocytes, as well as by improving dis-
turbance of the microenvironment. Additionally, re-
sults suggested that regulation of interactions between
BMECs and astrocytes could be an important target of
drug action on injured neurons and a novel path for
therapeutic intervention of ischemic injury.
It is not clear at present which signaling factor partici-
pates in information transfer between BMECs and as-
trocytes. In some cases, the BMECs or astrocytes are
both able to release cytokines and respond to them.
Therefore, in our study, the change of TNF-α, IL-1β,
BDNF, and GDNF, as the final effect, may simultane-
ously undertake the function of transmitting informa-
tion. Future studies are necessary to determine what
factors are involved and how TLJN regulates these sig-
naling factors.
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